Transcriptomics

Dataset Information

0

Targeting the HuR oncogenic role with a new class of inhibitors of HuR dimerization


ABSTRACT: Comprehensive meta-analysis and target screening confirmed that the mRNA-binding protein of ELAV-family HuR is oncogenic and universally upregulated in brain tumors, which highlight HuR as an universal chemotherapeutic target. HuR functionality in cancer cells is strictly dependent on HuR nuclear/cytoplasmic shuttling and dimerization; therefore, we developed a new class of inhibitors of HuR protein dimerization by utilizing medicinal chemistry techniques and reporter cell-based assay of HuR dimerization. The therapeutic potentials of lead compound (SRI-42127) were evaluated in five primary patient-derived glioma xenolines of classic, proneural, and mesenchymal subtypes, in vitro, and in mouse glioma model, in vivo. The Illumina global RNA-Sequencing was performed on PDGx-derived glioma neurospheres of different subtypes after treatment with DMSO (control) or SRI-42127 (3 uM) for 12 h to analysis transcripts and cell-signaling pathways affected by new inhibitor of HuR dimerization.

ORGANISM(S): Homo sapiens

PROVIDER: GSE158271 | GEO | 2020/11/05

REPOSITORIES: GEO

Similar Datasets

| PRJNA664706 | ENA
2010-11-10 | E-GEOD-25264 | biostudies-arrayexpress
2010-11-10 | GSE25264 | GEO
2021-01-28 | GSE165625 | GEO
2011-05-13 | E-GEOD-22288 | biostudies-arrayexpress
2018-07-23 | GSE108280 | GEO
2018-07-20 | GSE103417 | GEO
2011-05-13 | GSE22288 | GEO
2018-10-22 | GSE107836 | GEO
2011-08-18 | E-GEOD-29778 | biostudies-arrayexpress